NIH launches Phase I clinical trial of novel drug to treat Clostridium difficile infection
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial of CRS3123, an investigational oral antibiotic intended to treat Clostridium ...
Jul 9, 2014
0
0